Under construction – not a live service
Sign in
Taking people in DenmarkNo phase

Low-Calorie Diet for Fatty Liver in Adults Born With Low Birth Weight

Tests a 4-week low-calorie diet in adults born small with fatty liver.

Plain-language title generated from the registry record
Registry title: Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals

Key facts

Where
Aarhus and Herlev, DenmarkSee the 2 sites

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 35 and 40 years old?

Source: NCT05842850, who can take part

Where in Denmark

  • steno diabetes center AarhusAarhus, DenmarkTaking people
  • Steno Diabetes Center CopenhagenHerlev, DenmarkTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Steno Diabetes Center Copenhagen
Trial code
NCT05842850
Record updated
4 May 2026
Original description
The investigators will conduct a proof-of-principle 4-weeks low-calorie diet (LCD) intervention study in low birth weight (LBW) subjects and normal birth weight (NBW) controls with documented (MR scan) liver fat content equal to or above 5%. The investigators will provide extended in-depth mechanistic insight into the role of impaired subcutaneous adipose tissue (SAT) expandability in ectopic fat deposition before and after LCD.Read full original descriptionShow less

Increased Risk of Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals - Reversibility and Mechanistic Studies.

The investigators will conduct a proof-of-principle 4-weeks low-calorie diet (LCD) intervention study in low birth weight (LBW) subjects and normal birth weight (NBW) controls with documented (MR scan) liver fat content equal to or above 5%. The investigators will provide extended in-depth mechanistic insight into the role of impaired subcutaneous adipose tissue (SAT) expandability in ectopic fat deposition before and after LCD.

Inclusion: subjects with NAFLD (liver fat content ≥5% liver fat content verified on MRS in the screening NAFLD study).

Exclusion: Family history of diabetes (siblings, parent, and grandparents); Disease/medication known to affect primary outcome; Metabolic/liver disease; BMI<18.5 and BMI>30 kg/m2; Self-reported high physical activity level; Alcohol intake above general recommendations; Weight gain/loss of >3 kg within the past 6 months.

ClinicalTrials.gov NCT05842850